DocStoX is a free AI-powered research platform for Indian equity markets, covering 5,700+ NSE & BSE stocks with prices, fundamentals, 326 financial ratios, shareholding, FII/DII flows, F&O, IPOs, a visual screener and AI stock scoring.

Yes. DocStoX has a free tier covering stock research, the screener, FII/DII data and educational guides, plus a free MCP API tier (50 tool calls/day) for AI assistants. A Pro plan adds higher limits and advanced features.

What data does DocStoX cover?

Every NSE & BSE listed stock (5,700+ instruments): EOD and intraday prices, income statement / balance sheet / cash flow, 326 ratios, quarterly shareholding, promoter pledge, mutual-fund holdings, FII/DII flows, F&O and option-chain data, analyst forecasts, IPOs, corporate actions and news.

Can AI assistants like ChatGPT or Claude use DocStoX data?

Yes. DocStoX runs a public Model Context Protocol (MCP) server at https://mcp.docstox.com/mcp with 76 tools, so Claude, ChatGPT, Cursor and other MCP clients can pull Indian market data directly. Setup and a free key are at https://docstox.com/mcp.

Neutral impactCorporate Action

Alkem Laboratories Limited — Appointment

NSE 1 hr ago·15 Sept 2026, 3:38 pm

Alkem Laboratories

Alkem Laboratories has announced the appointment of Dr. Shubhadeep Sinha as a Senior Management Personnel, effective September 15, 2026. This strategic move indicates the company is strengthening its leadership team to support future growth initiatives.

For investors, this development signals a proactive approach to organizational planning. It suggests the company is preparing for upcoming challenges or opportunities by bringing in experienced leadership. This can be viewed as a positive step for long-term stability.

Investors should monitor the specific responsibilities assigned to Dr. Sinha and how his expertise aligns with Alkem's strategic goals. Following the announcement, keep an eye on any further details regarding his role and the company's future roadmap.